{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15719641", "DateCompleted": {"Year": "2005", "Month": "07", "Day": "12"}, "DateRevised": {"Year": "2008", "Month": "02", "Day": "06"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-5302", "JournalIssue": {"Volume": "30", "Issue": "3", "PubDate": {"Year": "2005", "Month": "Feb"}}, "Title": "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", "ISOAbbreviation": "Zhongguo Zhong Yao Za Zhi"}, "ArticleTitle": "[The protective effects of Fufang Biejiafang on bleomycin-induced pulmonary fibrosis in rats].", "Pagination": {"StartPage": "204", "EndPage": "207", "MedlinePgn": "204-7"}, "Abstract": {"AbstractText": ["To explore the possible effects and mechanism of Fufang Biejiafang on a single intratracheal instillation (IT) of bleomycin-induced lung fibrosis model.", "SD rats were treated with a single IT dose of bleomycin or control saline. Chinese medicine group were poured into the stomach after the first day of operation with high dosage, middle dosage and low dosage. On days 7, 14 and 28 following IT bleomycin or saline, 4 mL blood were taken from the abdominal aorta for arterial blood gas analysis. The left lung was fixed for routine light microscopic examination. Bronchoalveolar lavage fluid (BALF) from the right lung was tested the activity of pulmonary surfactant (PS) by the Whihelmy Film Balance, then the right lung was frozen immediately in liquid nitrogen for determination of hydroxyproline concentration.", "Model rats had obviously changes of body weight and hypoxemia and dysfunction of PS on days 7 and improved on days 14. Compared with three dose groups, the middle dose group some degreely improved and PS function. It ameliorate fibrosis because of inhibition of inflammation.", "(1) PS dysfunction resulted in hypoxemia after bleomycin injured alveolar type II (AT II). Fufang biejiafang-middle dose-group ameliorate hypoxemia by remission AT-II injury. (2) Fufang biejiafang may inhibit exudation inflammation and ameliorate fibrosis."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "The lab of cell and biochemistry, Beijing University of Chinese Medicine, Beijing 100029, China."}], "Identifier": [], "LastName": "Kong", "ForeName": "Lu", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Ji-feng", "Initials": "JF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Niu", "ForeName": "Jian-zhao", "Initials": "JZ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xia", "ForeName": "Zhi-gang", "Initials": "ZG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Qiao", "ForeName": "Chen", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wei", "ForeName": "Yan-fei", "Initials": "YF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tu", "ForeName": "Heng-jing", "Initials": "HJ"}], "PublicationTypeList": ["English Abstract", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhongguo Zhong Yao Za Zhi", "NlmUniqueID": "8913656", "ISSNLinking": "1001-5302"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Materia Medica"}, {"RegistryNumber": "0", "NameOfSubstance": "Protective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Pulmonary Surfactants"}, {"RegistryNumber": "11056-06-7", "NameOfSubstance": "Bleomycin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Bleomycin"}, {"QualifierName": [], "DescriptorName": "Blood Gas Analysis"}, {"QualifierName": ["cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Materia Medica"}, {"QualifierName": ["chemistry"], "DescriptorName": "Paeonia"}, {"QualifierName": ["chemistry"], "DescriptorName": "Panax"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protective Agents"}, {"QualifierName": ["chemically induced", "metabolism", "pathology"], "DescriptorName": "Pulmonary Fibrosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Pulmonary Surfactants"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": [], "DescriptorName": "Turtles"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "2", "Day": "22", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "7", "Day": "13", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "2", "Day": "22", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15719641"]}}], "PubmedBookArticle": []}